Evidence map›Paper›PMID 17342490›Full record

ReviewWorld journal of urology2007

Biopsy standards for detection of prostate cancer.

Bob Djavan, Markus Margreiter

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01752140 (A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01752140 nacompletednot on this mapstarted 2009, after this paper: background citation

A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme

TypeinterventionalSponsorHospital de Santa Maria, PortugalRan2009 to 2010Enrolled463ConditionsProstate CancerArms10-core prostate biopsy protocol, Vienna nomogram prostate biopsy protocol
3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Applications of transrectal ultrasound in prostate cancer.The British journal of radiology · 2012
    Article
  16. Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.IEEE/ASME transactions on mechatronics : a joint publication of the IEEE Industrial Electronics Society and the ASME Dynamic Systems and Control Division · 2012
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bob DjavanDepartment of Urology, Medical University of Vienna, Wahringer Gurtel 18-20, 1090 Vienna, Austria. bdjavan@hotmail.com
Markus Margreiter

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread use of measurement of prostate-specific antigen for prostate cancer screening has led to a dramatic increase in the number of transrectal biopsies. Although transrectal ultrasound-guided prostate biopsy is the gold standard in the diagnosis of prostate cancer, the strategies for initial and repeat biopsies remain controversial. Over the past decade numerous biopsy protocols have been developed. Several protocols have been established that increase the number of cores by combining sextant and lateral biopsies to increase the cancer detection rate. We review the current methods of prostate biopsies, the indication to perform an initial and repeat biopsy, the impact of prostate volume on the number of cores taken, and the morbidity of the procedure.

Indexed as

BiopsyHumansMaleMorbidityProstate-Specific AntigenProstatic Intraepithelial NeoplasiaProstatic NeoplasmsUltrasonographyProstate-Specific Antigen

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.